BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17531656)

  • 1. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?
    Tziakas DN; Kaski JC; Chalikias GK; Romero C; Fredericks S; Tentes IK; Kortsaris AX; Hatseras DI; Holt DW
    J Am Coll Cardiol; 2007 May; 49(21):2081-9. PubMed ID: 17531656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease.
    Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Chatzikyriakou SV; Mitrousi K; Kortsaris AX; Boudoulas H; Kaski JC
    Coron Artery Dis; 2008 Dec; 19(8):583-90. PubMed ID: 19005293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome.
    Tziakas DN; Chalikias GK; Tentes IK; Stakos D; Chatzikyriakou SV; Mitrousi K; Kortsaris AX; Kaski JC; Boudoulas H
    Eur Heart J; 2008 Nov; 29(22):2713-22. PubMed ID: 18765457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation.
    Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Papazoglou D; Thomaidi A; Grapsa A; Gioka G; Kaski JC; Boudoulas H
    Int J Cardiol; 2011 Jul; 150(1):22-7. PubMed ID: 20223535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total cholesterol content of erythrocyte membranes levels are associated with the presence of acute coronary syndrome and high sensitivity C-reactive protein.
    Yu MM; Xu Y; Zhang JH; Wang CH; Wang XC; Cheng ZP; Xu BL
    Int J Cardiol; 2010 Nov; 145(1):57-8. PubMed ID: 19411120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
    Tziakas DN; Chalikias GK; Antonoglou CO; Veletza S; Tentes IK; Kortsaris AX; Hatseras DI; Kaski JC
    J Am Coll Cardiol; 2006 Dec; 48(12):2471-81. PubMed ID: 17174184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell distribution width: a strong prognostic marker in cardiovascular disease: is associated with cholesterol content of erythrocyte membrane.
    Tziakas D; Chalikias G; Grapsa A; Gioka T; Tentes I; Konstantinides S
    Clin Hemorheol Microcirc; 2012; 51(4):243-54. PubMed ID: 22277951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome.
    Demirbag R; Yilmaz R; Gur M; Kocyigit A; Celik H; Guzel S; Selek S
    Mutat Res; 2005 Oct; 578(1-2):298-307. PubMed ID: 15985271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid levels after acute coronary syndromes.
    Pitt B; Loscalzo J; Ycas J; Raichlen JS
    J Am Coll Cardiol; 2008 Apr; 51(15):1440-5. PubMed ID: 18402897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect?
    Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Thomaidi A; Chatzikyriakou S; Mitrousi K; Kortsaris AX; Kaski JC; Boudoulas H; Konstantinides S
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):471-80. PubMed ID: 19838647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.
    Chalikias GK; Tziakas DN; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Int J Cardiol; 2007 May; 117(3):333-9. PubMed ID: 16859776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total erythrocyte membrane cholesterol: an innocent new marker or an active player in acute coronary syndromes?
    Arbustini E
    J Am Coll Cardiol; 2007 May; 49(21):2090-2. PubMed ID: 17531657
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins.
    Toutouzas K; Vaina S; Tsiamis E; Vavuranakis M; Mitropoulos J; Bosinakou E; Toutouzas P; Stefanadis C
    Am Heart J; 2004 Nov; 148(5):783-8. PubMed ID: 15523307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events.
    Liuzzo G; Biasucci LM; Trotta G; Brugaletta S; Pinnelli M; Digianuario G; Rizzello V; Rebuzzi AG; Rumi C; Maseri A; Crea F
    J Am Coll Cardiol; 2007 Oct; 50(15):1450-8. PubMed ID: 17919564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of plasma lipid profile in acute coronary syndromes. The use of fibrinolytics and heparin do not affect it significantly].
    Fattore L; Vetrano A; Melorio S; Schioppa M; Corsini F; Chieffo C; Corsini G
    Ital Heart J Suppl; 2000 Nov; 1(11):1451-6. PubMed ID: 11109195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelin in erythrocyte membranes increases the total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome.
    Zhang J; Tu K; Xu Y; Pan L; Wu C; Chen X; Wu M; Cheng Z; Chen B
    Coron Artery Dis; 2013 Aug; 24(5):361-7. PubMed ID: 23652364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.